Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05661851 · ClinicalTrials.gov registry record · Phase 2
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
A Phase 2 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
NCT05661851 is a Phase 2 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 121 participants.
The verdict
NCT05661851, a Phase 2 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
Study Summary
This is a 30-Day, multi-site, single-masked, bilateral, active- controlled, 2-Arm parallel group study to evaluate the safety and efficacy of an Investigational product.
Interventions
- DRUG Investigational Lubricating Eye Drop in a Novelia® bottle
- DRUG Blink® Tears eye Drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2023-02-23 |
| Est. Completion | 2023-04-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05661851
The ClinicalTrials.gov registry entry for NCT05661851 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational Lubricating Eye Drop in a Novelia® bottle is the first listed.
NCT05661851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05661851 about?
NCT05661851 is a clinical study titled "Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients". This is a 30-Day, multi-site, single-masked, bilateral, active- controlled, 2-Arm parallel group study to evaluate the safety and efficacy of an Investigational product.
What is the current status of trial NCT05661851?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2023-02-23. Estimated completion is 2023-04-27.
What interventions are being tested in trial NCT05661851?
The interventions under investigation include: Investigational Lubricating Eye Drop in a Novelia® bottle (DRUG), Blink® Tears eye Drops (DRUG).
Who is sponsoring clinical trial NCT05661851?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.